Recent Publications

 
  • Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet’s disease severity Kahraman T, Gucluler G, Simsek I, Yagci FC, Yildirim M, Ozen C, Dinc A, Gursel M, Ikromzoda L, Sutlu T, Gay S, Gursel I. Journal of Extracellular Vesicles, 6:1, 1284449, 2017
  • Effect of egg storage duration and brooding temperatures on chick growth, intestine morphology and nutrient transporters. Yalcin S, Gursel I, Bilgen G, Horuluoglu BH, Gucluer G, Izzetoglu GTAnimal. Feb 21:1-7, 2017
  • Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction. Gucluler G, Adiguzel E, Gungor B, Kahraman T, Gursel M, Yilmaz B, Gursel I, PLoS One. Feb 7;12(2): e0171003, 2017
  • Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development. Bayyurt B, Tincer G, Almacioglu K, Alpdundar E, Gursel M, Gursel I. Control Release, 247:134-144, 2017
  • Involvement of Sting-Activating Cyclic Di-Nucleotides on T-Cell Differentiation and Function: An Unresolved Issue. Yildiz B, Gursel I, Turkish J. Immunol, 4 (3), 47-51, 2016
  • Development of CpG ODN Based Vaccine Adjuvant Formulations Gursel M, Gursel I, Methods Mol Biol.;1404:289-98, 2016
  • Evidence-Based Clinical Use of Nano-sized Extracellular Vesicles in Nanomedicine. Stefano F, Borras F,  Buzás E, Camussi G, Cappello F, Carvalho J, Cordeiro-da-Silva A, Del Portillo H, El-Andaloussi S, Trcek TF, Furlan R, Hendrix A, Gursel I,  Kralj-Iglic V, Kaeffer B, Kosanovic M, Lekka M, Lipps G, Logozzi M,  Marcilla A,  Marei S, Llorente AM, Nazarenko I, O'Driscoll L,  Oliveira C,  Pocsfalvi G, Rajendran L, Raposo G, Rohde E, Siljander P, Van Niel G, Vasconcelos HM, Yliperttula ML, Mó MY, Zarovni N, Zavec AB, Giebel B. ACS Nano,10(4):3886-99, 2016
  • Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides. Bayik D, Gursel I, Klinman DM. Pharmacol Res. 105:216-25, 2016
  • Intestinal Microbiota in Patients with Spinal Cord Injury. Gungor B,  Adıguzel E,  Yilmaz B,  Gursel M, Gursel I. PLoS One, 11(1): e0145878, 2016
  • The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. Raza U, Saatci Ö, Uhlmann S, Ansari SA, Eyüpoğlu E, Yurdusev E, Mutlu M, Ersan PG, Altundağ MK, Zhang JD, Doğan HT, Güler G, Şahin Ö. Oncotarget. 2016 Jul 8.
  • miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer. Mutlu M, Saatci Ö, Ansari SA, Yurdusev E, Shehwana H, Konu Ö, Raza U, Şahin Ö. Sci Rep. 2016 Sep 7;6:32541.
  • Interplay between 15-lipoxygenase-1 and metastasis-associated antigen 1 in the metastatic potential of colorectal cancer. Tunçer S, Tunçay Çağatay S, Keşküş AG, Çolakoğlu M, Konu Ö, Banerjee S. Cell Prolif. 2016 Aug;49(4):448-59.
  • Functionally conserved effects of rapamycin exposure on zebrafish. Sucularli C, Shehwana H, Kuscu C, Dungul DC, Ozdag H, Konu O. Mol Med Rep. 2016 May;13(5):4421-30.
  • The pro-survival IKK-related kinase IKKepsilon integrates LPS and IL-17A signaling cascades to promote Wnt-dependent tumor development in the intestine.Goktuna SI, Shostak K, Chau TL, Heukamp LC, Hennuy B, Duong HQ, Ladang A, Close P, Klevernic I, Olivier F, Florin A, Ehx G, Baron F, Vandereyken M, Rahmouni S, Vereecke L, Van Loo G, Büttner R, Greten F, Chariot A. Cancer Res. 2016 Mar 15.